Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132303) titled 'Survey on treatment practice of von Hippel-Lindau Disease in China' on Sept. 11.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Peking University First Hospital
Condition:
von Hippel-Lindau disease
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-11
Target Sample Size: Research group(Physicians,Patients):162;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=339579
Published by HT Digital Content Services with permission from Health Daily Digest....